PATENT CLAIM ANALYSIS

Application Number: 15767328
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "236200"]

Abstract:
The disclosure provides compounds of formula (I) or pharmaceutically acceptable salts thereof: The disclosure also provides processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them, and their use as modulators of dopamine D 3  receptors, such as treating substance abuse or psychiatric diseases.

Claim (Index 44):
4-(3-{[4-methyl-5-(thiophen-3-yl)-4H-1,2,4-triazol-3-yl]sulfanyl)}propyl)-2-[4-(trifluoromethyl)phenyl]morpholine or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 91.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15522863', '15750128', '11911035', '11570623', '11569880']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8039916016019173
- 35 USC 102 Novelty (BERT): 0.54526494792162
- Combined Prediction Score: 0.7781189362338876
- Mean Citation Score: 334.188548
- Max Citation Score: 398.69064
- Similarity Product: 317.7921059526729

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test